Stock screener

JANX

SetupConviction 48LongHealthcareScan · Thu, Jun 25, 2026
Downtrendchannel
JANX$14.55-0.61%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 1.31M
Mar 26Apr 14May 1May 19Jun 8Jun 25

Trade plan

LongReward : Risk0.91
Entry
Entry
14.65
Risk
Stop
12.93
-11.8% to stop
Reward
Target 1
16.23
+10.8% to target
Stretch
Target 2
17.81
+21.5% to T2
Risk : reward balance
Risk to stopReward to target

Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.

Janux Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.januxrx.com ↗
Price14.55
Change-0.61%
Gap+0.58%
Rel volume6.24×
Avg volume1.16M
Avg $ vol16.41M
SMA 2014.00
SMA 5014.38
SMA 20017.86
Price vs 50+1.16%
Price vs 200-18.54%
MA stackmixed
50/200 cross—
Supertrenddown · 15.00
RSI (14)56
MACD hist0.14
MACD crossbull · 5d
Stoch %K / %D67 / 81
ADX (14)17
+DI / −DI21 / 11
RSI divergence—
MACD divergence—
ATR %+4.05%
ADR %4.03%
52w high34.74
52w low12.18
From 52w high-58.12%
Above 52w low+19.46%
New 52w highNo
SqueezeOff
Bollinger width14.36%
%B0.77
Donchian pos67.31%
Donchian high15.31
Donchian low12.99
AVWAP (52w high)15.04
vs AVWAP high-3.23%
AVWAP (52w low)14.15
vs AVWAP low+2.82%
OBV trendDown
Chaikin MF (20)-0.28
Today vs 20d6.24×
Avg vol (14d)1.31M
Avg vol (20d)1.16M
Avg $ vol (20d)16.41M
Market cap887.32M
RS 3m (vs SPY)-4.29%
RS 6m (vs SPY)-1.57%
RS line new highNo
Trend template1/8
Technical rank46.7
1 week+2.83%
1 month+1.04%
3 months+5.43%
6 months+3.26%
1 year-37.69%
YTD+6.59%
P/E-7.81
P/B0.94
P/S88.73
P/FCF-10.65
EPS-1.83
Div yield—
ROE-12.07%
ROA-11.05%
Debt/Eq—
Current17.01
EV/EBITDA—
Gross margin—
Net margin—
Rev growth-5.55%
EPS growth-64.69%
Price target31.00
Target upside113.06%
Analyst ratingBuy
Institutional103.17%
Ent. value835.49M
Revenue3.73M
Net income-24.36M
Gross profit—
Free cash flow-83.28M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out60.98M
Employees108
ListedFri, Jun 11, 2021
Free float37.06M
Float %61.6%
Short interest8.09M
Days to cover6.8d
Short volume19.1%
Squeeze score80 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$0.26 · 8 est
Last EPS vs est−$0.39 vs −$0.50
Last surprise+22.0% beat
Setup gradeC
Conviction48 / 100
Pattern quality65%
Tech rank46.7 / 100
Group rank50 / 100
Status laneSetting up
Setup directionLong
Pattern familyChannel
Resistance14.65
Support13.07
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 16 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Jun 22
    1 scan
  2. Breaking out now
    Jun 23
    1 scan
  3. Broke out
    Jun 24
    1 scan
  4. Setting up
    Jun 25
    1 scan

Congress activity

Disclosed STOCK Act trades in JANX

All disclosures →
No recent disclosed trades by Congress in JANX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in JANX · 2 buys · 2 sells

InsiderSideShares
Barrett Ronald W
Director · Common Stock · 2026-06-11
Grant5.5K
Barrett Ronald W
Director · Stock Option (right to buy) · 2026-06-11
Grant15.5K
Doyle Janeen Noel
Chief Corp. & Bus. Dev. Ofcr · Common Stock · 2026-06-02
Sell4.06K
Dobek Maria
Vice President, Accounting · Common Stock · 2026-05-11
Sell2.04K

SEC filings

EDGAR filings in JANX · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.